Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI

Clinical trial NCT01812213 · TERMINATED

Trial details

NCT number: NCT01812213
Sponsor: Navidea Biopharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment

Start date: 2013-03-01
Primary completion: 2017-11-02
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.